SRGAP2 and colorectal carcinoma: found that the SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) can bind to and directly interact with mitochondrial Complex I (CI), enhancing its activity, which in turn inhibits the sensitivity of CRC cells to chemotherapy.